BOLNO PAUL
President and CEO
BOLNO PAUL has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Feb 11, 2026.
On the most recent filing, BOLNO PAUL is listed as President and CEO at Wave Life Sciences Ltd. Inside the rolling window, BOLNO PAUL reported no open-market purchases and 1 open-market sale totaling $141K in WVE.
Companies traded
Other insiders at WVE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$141K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has BOLNO PAUL made?
BOLNO PAUL has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does BOLNO PAUL trade?
BOLNO PAUL has filed SEC Form 4 disclosures for 1 company, including WVE.
When was BOLNO PAUL's most recent SEC Form 4 filing?
BOLNO PAUL's most recent SEC Form 4 filing on Tracefour is dated Feb 11, 2026.
What is BOLNO PAUL's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, BOLNO PAUL is listed as President and CEO.
What is BOLNO PAUL's total buy and sell value in the current window?
Inside the rolling retention window, BOLNO PAUL bought $0 and sold $141K based on SEC Form 4 filings.
What was BOLNO PAUL's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,480 WVE shares on 2026-02-09, worth $141K, per SEC Form 4 filings.